Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Danske Bank in connection with a SEK 750 million credit facility for Svenska Retursystem
Mandate

Vinge has advised Danske Bank in connection with a SEK 750 million credit facility for Svenska Retursystem

February 16, 2023 Banking and Finance

Vinge has advised Danske Bank A/S, Danmark, Sverige Filial in connection with the signing of a new SEK 750 million credit facility for Svenska Retursystem Aktiebolag.

The credit facility has a tenor of three years with built-in extension options and the parties intend to set certain KPIs whereby the interest rate of the credit facility will be conditional on the company’s achievement of certain set sustainability based targets. The funds shall be used to, inter alia, refinance existing debt and for general corporate and working capital purposes.

Svenska Retursystem’s circular system enables food producers, wholesalers, shops and restaurants to work together to optimise the food industry's supply chain.

Vinge’s team consisted of Albert Wållgren, Arvid Weimers and Karl-Gustaw Tobola.

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025